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Introduction: Research capacity building is a critical component of professional
development for pediatrician scientists, yet this process has been elusive in the
literature. The ECHO IDeA States Pediatric Clinical Trials Network (ISPCTN) seeks
to implement pediatric trials across medically underserved and rural populations. A
key component of achieving this objective is building pediatric research capacity,
including enhancement of infrastructure and faculty development. This article presents
findings from a site assessment inventory completed during the initial year of
the ISPCTN.
Methods: An assessment inventory was developed for surveying ISPCTN sites.
The inventory captured site-level activities designed to increase clinical trial research
capacity for pediatrician scientists and team members. The inventory findings were
utilized by the ISPCTN Data Coordinating and Operations Center to construct training
modules covering 3 broad domains: Faculty/coordinator development; Infrastructure;
Trials/Research concept development.
Annett et al. ISPCTN Capacity Building
Results: Key lessons learned reveal substantial participation in the training modules,
the importance of an inventory to guide the development of trainings, and recognizing
local barriers to clinical trials research.
Conclusions: Research networks that seek to implement successfully completed
trials need to build capacity across and within the sites engaged. Our findings indicate
that building research capacity is a multi-faceted endeavor, but likely necessary for
sustainability of a unique network addressing high impact pediatric health problems.
The ISPCTN emphasis on building and enhancing site capacity, including pediatrician
scientists and team members, is critical to successful trial implementation/completion
and the production of findings that enhance the lives of children and families.
Keywords: clinical trials, ISPCTN, pediatrics, network, research capacity building
INTRODUCTION
Clinical trial funding has historically been confined to large
academic centers with largely urban populations and limited age
groups of children (1). Likewise, populations under-represented
in pediatric trials often are rural, medically underserved,
and economically disadvantaged (2). Involvement of medically
underserved and rural populations is critical to addressing health
conditions affecting the most vulnerable populations of children
in the country. These groups often have high rates of infant
mortality (3), asthma (4), and childhood obesity (5).
The ECHO IDeA States Pediatric Clinical Trials Network
(ISPCTN), funded and established by the National Institutes of
Health (NIH) in 2016 as a component of the NIH Environmental
Influences on Child Health Outcomes (ECHO) program, is
unique in its geographic composition and diverse in its ethnic and
racial makeup (Figure 1). Characterization of these differences
have recently been published (6). Clinical trial networks, such
as the ISPCTN, represent an effective, efficient, and cost
effective method for the creation of high quality, generalizable
research (7). Networks typically consist of formal arrangements
between individuals, institutions, and key stakeholders designed
to facilitate the development, implementation, operation and
completion of clinical trials (8, 9). As a new network charged to
produce impactful pediatric research, building research capacity
among sites was an initial ISPCTN priority to ensure that the
nascent network could meet the challenges of conducting state-
of-the-art research for underserved pediatric populations.
Capacity building has been defined as “a process of individual
and institutional development which leads to higher levels of
skills and greater ability to perform useful research” (10). Within
the ISPCTN, building capacity was broadly operationalized
to include faculty/coordinator development, enhancement and
expansion of infrastructure, and enrichment of trials/research
concept development (Table 1). These broad domains align with
Abbreviations: NIH, National Institute of Health; ECHO, Environmental
Influences on Child Health Outcomes; ISPCTN, ECHO IDeA States Pediatric
Clinical Trials Network; DCOC, Data Coordinating and Operations Center; IRB,
Internal Review Board; MRI, Magnetic Resonance Imaging; NICU, Neonatal
Intensive Care Unit; HER, Electronic Health Record.
existing literature (11, 12). Additional elements crucial for long
term success include building a research culture, providing
mentorship, developing mechanisms for results dissemination,
and supporting ongoing sustainability (8, 13–16). Extant
literature largely focuses upon capacity building for allied health
professionals or capacity building in global health settings
(14, 17–20). Unfortunately, limited information exists regarding
building research capacity for pediatric clinical trial operations
(9, 21–24).
What can be determined from the existing literature, however,
is that several barriers to building research capacity include a
lack of funding, insufficient physical resources, limited research
experience and expertise, competing priorities, administrative
barriers, and lack of time for faculty and coordinators (8). To
overcome barriers and achieve the goal of building pediatric trials
capacity, an “all teach-all learn” model (25) integrated capacity
building activities and locally developed training modules across
all sites within this single award. The all teach-all learn
model arose from quality improvement work and supports
bidirectional learning, particularly focused on community health
improvement (26).
Here we aim to describe findings from an ISPCTN pediatric
research capacity inventory and to highlight the parallel
development of a professional development curriculum, as well
as qualitative reports of site-specific learning activities aimed at
enhancing pediatric research capacity. Three primary capacity
domains are presented: faculty/coordinator development,
enhancement and expansion of organization-institutional
infrastructure, and clinical trials/research concept development.
MATERIALS AND METHODS
Assessment Inventory
In the 1st year of ISPCTN, each awardee site principal
investigator and affiliated sites were sent a REDCap site
assessment inventory, developed by the Data Coordinating
and Operations Center, in December 2016 (∼2 months after
sites received initial funding). The inventory was completed by
each site and affiliated site(s) prior to Network trial initiation.
The domains of the inventory sought to identify and describe
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FIGURE 1 | ECHO IDeA States Pediatric Clinical Trails Network 17 Clinical Sites and DCOC*A.
existing infrastructure and was used as a tool to inform the
overall capacity building needs of the Network prior to trial
initiation, thus did not meet the 45 CRF 46 definition of
research. The inventory consisted of 57 multiple-choice and
open-ended questions.
Inventory domains and description of content questions
are outlined in Table 1. Special pediatric populations were
ascertained using the total reported number of active pediatric
patients seen at each site annually. Sites then reported subgroups
from ECHO priority areas (airway, obesity, neurodevelopment,
prenatal/perinatal/postnatal, positive child health) and patient
demographic characteristics. Recruitment capacities at sites were
characterized by languages spoken at associated clinics, need and
ability to provide multi-language recruitment materials, hours
of operation, recruitment methods and requirements needed for
recruitment activities.
Other site capacities were inventoried. These included a
human subjects review domain that ascertained information
regarding regularity of Institutional Review Board (IRB)
meetings and possible obstacles to timely reviews. The study
monitoring domain collected site information including location
of source documents stored in medical records and the ability to
accommodate monitor visits, including work space and access
to medical record (paper/electronic). The laboratory domain
assessed site access to a local laboratory for specimen processing
and dedicated equipment (e.g., centrifuge, refrigerator, and
freezer). Sites were also assessed for imaging capabilities,
including the availability of pediatric facilities for X-ray andMRI.
Facilities questions elicited information on infrastructure
available for research, including neonatal intensive care unit
(NICU) presence at the site, dedicated pediatric research space,
investigational pharmacy, storage for lab supplies, practice
management system, and medical records. Information was
obtained on electronic/mobile health communication and if sites
were tracking mobile device usage in their patient community.
The data management domain included the availability of
EHR resources.
Curriculum Development
Professional development curriculum and site-developed
training modules were created by the DCOC. The professional
development curriculum was comprised of learning themes
(Table 2). These were developed from DCOC expert input,
based upon research trainings offered through the Arkansas
Translational Research Institute and guided by the ISPCTN
mission that includes engaging rural and underserved
communities. Thus, core learning themes included: clinical trials
essential elements, Institutional Review Board/ethics/regulatory
teachings, data management, and community engagement. To
further foster the development of pediatric scientists, a learning
theme providing opportunities for interaction with a pediatric
researcher was implemented. Finally, several specific professional
development offerings were created from participant requests.
RESULTS
Inventory Findings
Overall, 17 ISPCTN sites and 7 affiliates are predominantly at
academic medical centers (83%; 20 of 24 total responses), with
sites also including Tribal health organizations and primary
care centers.
Faculty and Coordinator Development
All ISPCTN site principal investigators reported having clinical
trials expertise [100% (n = 24) reporting previous experience
with clinical trials] in ECHO disease priority domains; with
17 of 24 principal investigators reporting participation in a
clinical trials network. However, variability was observed. ECHO
domains with the greatest site investigator trial expertise were
perinatal outcomes (n = 17), obesity (n = 17), and airway
diseases (n = 18) (range 71–75% of investigators reporting trial
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TABLE 1 | Initial site capacity inventory domains.
Domain Inventory content description
Faculty/coordinator
development
• Research experience within the ECHO
priority areas
◦ Upper and lower airway disease
◦ Pediatric obesity
◦ Neurodevelopment
◦ Positive child health
◦ Pre-, peri-, and post-natal outcomes
• Recruitment experience in special pediatric
disease populations and communities
Infrastructure • Human subjects review
• Study monitoring
• Available laboratories
• Facilities and equipment




• Domains for trainings developed and
implemented by the DCOC






Mentorship • DCOC provided content
• Site-specific research capacity
building activities
Research Culture • Site-specific research capacity
building activities
Dissemination of results • DCOC provided content
• Site-specific research capacity
building activities
Sustainability • DCOC provided content
experience in these domains). Less trial experience was observed
in positive child health and neurodevelopment [67% (n = 16)
and 50% (n = 14) of investigators reporting trial experience,
respectively]. Among study coordinators, less trial experience
in ECHO domains was reported [38–42% (n = 9–10) with
previous experience].
Experience With Recruitment Approaches
A broad range of recruitment approaches were identified. Most
popular methods were flyer, mailings and attending health fairs,
with 71–88% (n = 17–21) of sites favoring these approaches.
Recruitment methods utilized by <10% of sites included:
provider recruitment (n = 2), referral from hospital/clinic staff
(n = 2), websites (n = 2), 3rd party recruitment companies (n
= 1), patient registries (n = 1), e-newsletters (n = 1), word of
mouth (n = 1) and Instagram© (n = 1). E-media use included
Facebook© (54%; n= 13) and Twitter© (25%; n= 6).
Affiliate Needs
Knowledge gaps in regional affiliates that some sites had
partnered with to promote clinical trials recruitment were
identified. Local study conduct procedures and follow-up
education were identified to increase the number of trained
clinical investigators and research coordinators conducting
clinical trials for children in rural and underserved communities.
Infrastructure (Facilities and Equipment)
Most ISPCTN sites had facilities critical to implementation
of pediatric trials. NICUs were identified at 79% (n = 19)
of sites, while other on-site facilities were frequently present
[on-site pharmacy was reported at 93% (n = 20) of sites;
neuroimaging facilities on site ranged from 83 to 92%; n =
20–22]. However, research pharmacy capacity for investigational
agents was reported at fewer sites (79%; n = 19). Infrastructure
for biosample storage and shipping, research refrigerator and
freezer availability, and refrigerated centrifuges were frequently
reported [92–96% (n= 22–23) of sites].
Access to Electronic Health Records
A majority of our sites use electronic medical records (20 of 24
total responses reporting use of electronic medical records), with
EPIC and Cerner being the most common (22 of 30 sites and
subsites) of those using electronic medical records.
Electronic/Mobile Health Communication
Patient communication through email occurs at many sites (75%;
n= 18 of 24), though text messaging is less often used (38%; n=
9). However, across all sites, the estimated percent of patients with
an email address was 60% (median). A high level of enthusiasm
was evident for using e-communication for collection of research
data [96% (n = 23) of sites expressing interest in this modality],
though relatively few actively collect information on patient
mobile capabilities (25%; n= 6).
Trials/Research Concept Development
The DCOC provided a curriculum in an effort to increase the
capacity for investigators and coordinators to develop research
concepts. Training domain, content area, training focus and
number of attendees for DCOC-built modules are presented
in Table 2. There is no information available on participants
who viewed the archived recordings of these trainings. The
range of participants for each live module varied, as these were
voluntary trainings. Due to the diverse location of sites, modules
included a combination of operational as well as conceptual
topics. The DCOC facilitated communication and collaboration
across the network sites, resulting in shared content, practices,
and resources through an all teach-all learn model, which
provided opportunities for bi-directional learning, as well as
access national expertise for specific gaps and resource needs.
These modules covered a wide range of basic and applied
skills and were implemented beginning the 1st year of Network
operations and into the 2nd year.
Site-Specific Learning Activities
These learning and capacity building activities were developed
utilizing a combination of ISPCTN and local site resources.
Each network site focused on areas of local need, as determined
by site leadership, and shared between sites and the Network.
Table 3 highlights the qualitative findings of learning activities
developed and conducted by sites, and grouped by the capacity
building inventory domains. Network funding played a role
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TABLE 2 | DCOC led faculty and coordinator development trainings.
Domain and topic Training focusa Participant total Capacity building domainb
30min with a research mentor series
• 30min with a research mentor–pediatric faculty 1 I/S 4 M
• 30min with a research mentor–pediatric faculty 2 I/S 16 M
• 30min with a research mentor–pediatric faculty 3 I/S 13 M
• 30min with an ISPCTN researcher–pediatric faculty 4 I/S 18 M
• 30min with a research mentor: PK research–pediatric faculty 5 I/S 28 M
• 30min with a research mentor–pediatric faculty 6 I/S 14 M
IRB/ethics/regulatory
• Single IRB & role of the IRB in pediatric research H 37 I
• Pediatric assent and ethical considerations H 45 I
• Understanding the effects of health literacy on informed consent H 26 I
• The ethics of human subjects research H 32 I
• Informed consent (module only) H 3 I
• The influences of health literacy on clinical research trials H 22 TCD
Community engagement
• Community engagement in clinical research R 31 TCD
• Disparities affecting children among the American Indian communities R 25 TCD
• Conducting clinical trials in rural populations R 47 TCD
• Role a community advisory board plays in your research study I/S 51 TCD
Clinical trials essentials
• Overview of data safety monitoring boards S 28 F/CD
• Research record keeping: essential practices for your research team S 69 I
• Phases of a clinical trial S 10 F/CD
• Protocol deviations (module only) S 1 I
• Research misconduct S 7 F/CD
• Emergency use of investigational products and devices S 24 TCD
Data management
• Data definition and data management D 22 I
• Data management at clinical sites D 19 I
• Reliable data collection D 16 I
Other
• Advertising your research study E 24 I
• Lessons learned from the protocol review committee I/S 27 I
• Expanded access to investigational drugs I/S 40 TCD
• Writing for publication I/S 55 D
• Science departments & science advocacy I/S 1 RC
• Write winning grant proposals I/S 8 S
aPrimary Training Focus: I/S, Investigator/Staff; R, Recruitment; H, Human subjects; S, Study monitoring; L, Laboratories, facilities and equipment; E, Electronic/Mobile health
communication; D, Data management.
bCapacity Building Domains: F/CD, Faculty/Coordinator Development; I, Infrastructure; TCD, Trial/Research Concept Development; M, Mentorship; RC, Research Culture; D,
Dissemination of results; S, Sustainability.
in sites initiating interaction with local infrastructure resources
to support pediatric trials. Table 3 provides more nuanced
information on site generated topics including mentoring,
constructing an institutional research culture and activities for
promotion of sustainability.
DISCUSSION
Developing research capacity in a newmultisite network involves
many intersecting priorities, including prioritization of activities
at the site and Network levels. Clinical trials capacity building
for the ISPCTN benefited from guidelines in the extant literature
(13, 27). The ISPCTN site assessment inventory during the
initial year of funding revealed considerable pediatric-specific
research capacity. This Network, including academic and non-
academic sites, was led by principal investigators with clinical
trials experience. Most of the Network sites had existing capacity
for pediatric imaging and biosample storage facilities, as well
as clinical services that could be engaged in research (e.g.,
NICUs). With this enhanced understanding of within and
between site capacity variability, the DCOC developed and
implemented training modules to complement and enhance
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TABLE 3 | ISCPTN capacity development activities developed and conducted by sites.
Domain Site developed content
Faculty/coordinator development Research Boot Camp: provided a group lecture and small group tutorial sessions.
Community seminars focused on concepts, practices and ethics of community outreach.
General clinical trials training such as CITI, Good Clinical Practice and grants management.
ISPCTN trial-specific trainings for academic pediatricians and coordinators.
Pediatrics faculty-specific development plans, including research mentoring.
Pediatric Trials Network opportunities to expand opportunities for early career faculty and build site capacity.
Linking early career faculty to research seminars in other related departments (e.g., Maternal Fetal Medicine Research
Seminar).
Participation in national coordinator trainings encouraged and funded (e.g., joining Society of Clinical Research Associates:
SOCRA).
Clinical Research Education for the Workforce program for coordinators developed by the parent university.
Participation in existing programs, including:
• CITI Advanced Clinical Research Coordinator Essentials.
• University of Washington Biostatistics Bootcamp.
• DIA Clinical Research Fundamentals Bundle.
• Northwestern University Coordinator Bootcamp
Infrastructure Monthly meetings structured around the Joint Task Force for Clinical Trial Competency Core Competency Domains (source:
https://mrctcenter.org/clinical-trial-competency/).
Laboratory “scavenger” hunt to foster finding and engaging hard to identify people and data required to do pharmacokinetic
work.
Development and implementation of recording system to ensure all training requirements are met and covered prior to
beginning of study.
All coordinators and research staff are responsible for helping educate and cross-train new members of the research team
(shadowing for study clinic visits, consenting process, lab processing, etc.).
Coordinator surveys result in targeted competency areas and served to guide training sessions.
• Survey created and used was based on: Global self-assessment of competencies, role relevance, and training
needs among clinical research https://mrctcenter.org/clinical-trial-competency/wp-content/uploads/sites/5/2019/08/
2016-12-Global-Self-Assessment-survey-publication.pdf.
Competency areas were identified using the following:
• Leveling the Harmonized Core Competency Framework for the Clinical Research Professional Version 3.0 https://
mrctcenter.org/clinical-trial-competency/wp-content/uploads/sites/5/2019/01/2018-12-05-Core-Competencies-
Leveling-Summary.pdf.
Mentorship Pediatrics faculty-specific research mentoring to identify ISPCTN opportunities, skills training needs and junior faculty
strengths.
Group/individual mentoring, including:
• Development and implementation of routine mentoring sessions
• Structured agenda for mentoring meeting:
a. Special topic of interest to junior faculty (e.g., managing a research team, preparing a budget)
b. Sharing of one research success plus one goal for the next meeting;
c. and Research progress update from one faculty member.
Site investigators link early career faculty to trials in development and activation at the siter and/or within the ISPCTN.
Linking mentored early career faculty with ISPCTN writing committees.
Early career faculty mentored on development of scholarly work (e.g., abstract/manuscript development).
Group-based mentoring in grants management, recruitment, and the development of scholarly work products (posters,
presentations and manuscripts).
Short-term focused mentoring on specific scholarly activity (e.g., abstract preparation and submission).
For experienced coordinators, support for mentoring new coordinators at the site and across the network.
Weekly team meetings used as opportunity for mentoring of faculty and coordinators.
Research culture Outreach efforts to identify key stakeholders that build state-wide collaborations.
ISPCTN investigator membership within site’s Center for Clinical and Translational Research (CCTR)/Clinical and
Translational Science Awards (CTSA) Program leadership.
Collaboration with IDeA Clinical and Translational Science Center professional development core at the local site.
Dissemination of results IDeA regional conference attendance and presentations.
Outreach specific to the local and national American Academy of Pediatrics meetings.
Sustainability Institution hosts a Summer Research Scholar Program for medical students between their 1st and 2nd years of medical
school.
Program funds students to gain exposure to basic or clinical research early in their medical school career.
Pediatric residents linked with faculty to develop scholarly work linked to ISPCTN disease-specific areas of interest.
Research and trials concepts/scientific rigor Community engagement teaching focused on community advisory boards and guidelines for feedback to pediatric
researchers.
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knowledge and skills across ISPCTN faculty and coordinators
in many of the identified domains needed for research skill
development. As evident in Table 2, considerable efforts from
the DCOC were directed to building and presentation of
modules. Attendance by site faculty/coordinators suggests a
high level of utilization. The skill-focused approach to capacity
building, leveraging pre-existing site expertise, has allowed the
Network members to build expertise more uniformity than
if each site were providing local education. Having training
content available across all sites, regardless of size or local
expertise, formed a foundation of shared research mission and
helped create shared experiences that fostered further lines
of communication between site teams. Thus, key principles
for capacity building, such as site-to-site collaboration, were
emphasized through the inventory and subsequent training
modules (27).
From our inventory we learned that capacity for pediatric
trials rests upon several factors, including the type of trial (e.g.,
randomized controlled, pragmatic public health directed), other
necessary physical attributes (e.g., presence an investigational
pharmacy), and site training needs. Imperative in the inventory
findings, we find three necessary elements that are of greatest
importance: (a) having site leadership with trial experience;
(b) providing skills-focused training for investigators and
coordinators; and (c) supporting site infrastructure, such
as protected time for development and conduct of trials.
Our inventory provided the Network with simple metrics
about sites and identified several areas where variability was
evident (e.g., 17% of sites not using an electronic medical
record). An inventory approach to determining site and
Network capacity for clinical trials has not been evident in
the extant literature on capacity building, thus the current
presentation fills a gap in providing domains and context
that may be a useful startup activity for new research teams
and new networks. For the ISPCTN, the inventory findings
were disseminated to sites in two ways: a document was
developed and disseminated, and findings shared/discussed at
a steering committee meeting. This approach was intended to
motivate site teams to action that would facilitate the successful
conduct of trials through active support and engagement in
Network trials.
In the initial year of funding sites were invited to share
and build upon tools and activities established, as well as draw
upon and contribute to the centralized activities provided
by the DCOC. The ability for sites to augment Network
knowledge as a whole, and for the Network to augment
the capacity of sites, was a crucial element of the capacity
building approach adopted. Best practices were identified
and shared, exemplifying the bi-directional commitment
to accelerating pediatric trial capacity development. The
ISPCTN was thus built upon existing site capacities for
pediatric trials research, which could be more rapidly advanced
together, while developing research capacity and Network
culture, essential for successful implementation of multi-site
pediatric trials.
From the assessment inventory and curriculum development,
several important lessons stand out.
Lesson 1: Research Education Matters
Educational opportunities provided by a central coordinating
center, such as online training modules, provides an efficient,
effective mechanism for engaging multiple sites, establishing
shared operating procedures, and providing uniform knowledge
for pediatric trials. Sites within the Network brought a range
of individual and institutional expertise, from those sites where
individuals had limited trials research knowledge and limited
staff expertise, to those that had participated in networked trial
groups (e.g., the Pediatric Trials Network, Pediatric Emergency
Care Applied Research Network). Institutional resources for
research have been supported by the ISPCTN, serving as a
stimulus to support the development of pediatrician scientists.
Centralized training has facilitated the development of common
trials knowledge for pediatric faculty and staff.Module utilization
suggests several training topics received generally greater
participation (e.g., research record keeping), indicating training
gaps that were not necessarily anticipated. The modules have
provided a foundation that is being further built upon with the
implementation of network trials and associated trial-specific
trainings. We anticipate that both individual and institutional
trials expertise will continue to develop as a range of pediatric
trials are opened across the Network. Pediatric academic research
training is a continuous and career long endeavor that needs
to constantly be updated through professional development
activities, which the ISPCTN recognizes and is addressing.
Lesson 2: Assessing Local Site
Resources/Experience Before Trial Launch
Characterizing infrastructure prior to the initiation of pediatric
clinical trials provides necessary information, yet alone is
insufficient for operationalizing trials for children in rural and
medically underserved communities. This is particularly true
across a network that have diverse pediatric health issues that
are the focus for trials. The inventory findings suggest the
need for teams with less trials research background or for
those who have not received training in clinical trials need to
be provided with learning opportunities that increase research
skills necessary for successful trial completion. Missing in our
inventory, however, was a clearer characterization of site leaders’
experiences with different types of trials (e.g., industry trials,
investigator-initiated trials, adaptive and pragmatic trials). While
multi-site trials experience is clearly essential and important for
building capacity, it is also heterogeneous, and opportunities for
scholarly productivity from some trials may be limited to more
seasoned investigators.
Lesson 3: Identify Site Facilitators and
Barriers to Trial Implementation
Capacity building for pediatrician scientists and coordinators
must include a determination of local resources and barriers to
research. Barriers may include (a) protected research time in
order to establish and develop pediatrician scientists and (b)
implementation of pediatric trials within rural and medically
underserved communities. While this presentation addresses
network capacity and development from that perspective,
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the ability to establish a research culture within a site
and within rural communities is an important element of
sustainability. Local institutions and departments developing
new programs may identify administrative challenges, such as
developing grant budgets and contracts. Departmental priorities
for clinical productivity and teaching, as well as balancing
professional commitments, can have an impact upon scholarly
productivity. Similarly, building sustained relationships with
underserved communities requires identification of community
champions and the development of trusting relationships
between investigators and community members. These and
other factors (e.g., sufficient mentoring, protected time) will be
important to assess in future capacity assessment inventories,
as they play an indirect, but instrumental role in the success of
the network.
Network capacity rests upon the sites that can successfully
operationalize pediatric trials while embracing principals that
support research accomplishments (27). Findings presented here
provide a high-level overview of site capabilities. In order
to address the mission of increasing pediatric scientists, sites
developed a variety of strategies for building research skills in
experienced faculty, early career pediatric faculty, coordinators,
pediatric residents/fellows and medical students. A more
complete understanding of the scope of the training modules, the
rationale that drove local development, and the support for these
local activities would be valuable in developing an understanding
of the diversity of local research cultures and thus the potential
for sustainability. Discussion of these activities through Network
presentations (via steering committee calls and meetings)
has fostered collaborative research activities. Moreover, these
collaborations have resulted in scientific presentations, such as
those through IDeA regional conferences and academic pediatric
national/international meetings.
LIMITATIONS
Research capacity building for multi-site pediatric clinical trials
has been inadequately described in the literature. While our
presentation serves to increase available information, there are
several shortcomings with our approach. First, our approach
identified research infrastructure capacities across sites, yet did
not specifically focus on pediatric research needs assessments
of individual sites and individual investigator research needs.
Rather than an inventory, a needs assessment encompassing
early career, senior faculty, and coordinators could provide
greater depth of appreciation of gaps within and across sites.
Additionally, sites did not provide their full educational and
trainingmaterials, butmay have provided topics that were unique
or demonstrated a particular area of interest, and were not meant
to be comprehensive of their full curricula.
CONCLUSIONS
Identifying features of ISPCTN site has been a remarkable
adjunct to the competence areas that are needed in a multi-
site network. Professional development has only recently been
identified as a competency area in pediatrics (28). Pediatrician
scientists face similar challenges in increasing their knowledge
of research-specific skills, including the conduct of pediatric
trials. A major emphasis in the original development of ISPCTN
was not simply to develop a trials network, but to create
and sustain pediatric researchers with a firm commitment to
clinical trials addressing high frequency child health conditions
among communities that are historically underserved and
underrepresented in trials research.
Descriptions of the implementation of trials networks have
typically focused upon developing network priorities and
research agendas (29–32), yet have seldom addressed the capacity
of the research teams to implement trials (33). Building a
research network and teams have been reported to carry unique
challenges and burdens (34, 35) and our experiences demonstrate
the variety of needs that must be assessed and monitored over
time in order to identify learning gaps that may develop at
the site and/or team level. As our network matures, devoting
time to continuing to develop capacity through the domains
of research culture, dissemination of results, and sustainability,
will be important areas of focus. Together with the ever-
important need for enhancing scientific rigor, the next phase
for professional development for pediatrician scientists should
include measurement of qualitative indices along with trial
implementation/completion and the associated scholarly work
products. With the successes to date, we are confident that the
ISPCTN can succeed and prosper.
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